Header cover image

Bangladeshi (DSE) Pharma Industry Analysis

UpdatedJun 27, 2022
DataAggregated Company Financials
Companies16
  • 7D-0.6%
  • 3M-2.4%
  • 1Y11.7%
  • YTD-1.9%

The Pharma industry has been flat over the last week, but Beximco Pharmaceuticals has lost 3.1%. The past year has been better, since the industry has gained 12% in that time. Looking forward, earnings are forecast to grow by 12% annually.

Industry Valuation and Performance

Has the Bangladeshi Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Mon, 27 Jun 2022৳532.9b৳172.6b৳34.7b21.5x
Wed, 25 May 2022৳531.8b৳171.9b৳34.6b23x
Fri, 22 Apr 2022৳561.8b৳169.2b৳34.3b24.9x
Sun, 20 Mar 2022৳546.7b৳169.2b৳34.3b26.2x
Tue, 15 Feb 2022৳570.6b৳169.3b৳34.4b23.8x
Thu, 13 Jan 2022৳552.0b৳166.5b৳32.5b23.4x
Sat, 11 Dec 2021৳557.5b৳157.6b৳30.0b27.1x
Mon, 08 Nov 2021৳549.1b৳146.9b৳26.0bn/a
Wed, 06 Oct 2021৳597.1b৳145.3b৳25.4b29.7x
Fri, 03 Sep 2021৳550.5b৳151.7b৳25.7b26.7x
Sun, 01 Aug 2021৳519.7b৳151.7b৳25.7b26.2x
Wed, 05 May 2021৳474.2b৳151.7b৳25.7b18.9x
Sat, 06 Feb 2021৳470.5b৳148.4b৳24.6b21.7x
Tue, 10 Nov 2020৳388.6b৳143.5b৳23.9b19.6x
Mon, 03 Aug 2020৳348.5b৳139.4b৳23.0b19.2x
Thu, 07 May 2020৳321.3b৳140.3b৳24.7b13.8x
Sun, 09 Feb 2020৳347.7b৳135.7b৳24.7b15.4x
Sat, 02 Nov 2019৳373.4b৳134.1b৳24.1b18.8x
Tue, 06 Aug 2019৳382.6b৳131.0b৳23.7b17.5x
Median PE Ratio

18.7x


Total Market Cap: ৳398.1bTotal Earnings: ৳23.7bTotal Revenue: ৳131.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Bangladeshi Pharma Industry Median PE3Y Average 20.8x202020212022
Current Industry PE
  • Investors are relatively neutral on the industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 16.8x.
  • The industry is trading close to its 3-year average PS ratio of 3.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 14% per year over the last three years.
  • Revenues for these companies have grown 9.6% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Bangladeshi Pharma compare with similar industries?

BD Market-0.47%
Healthcare-0.72%
Pharma-0.61%
Pharma-0.61%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SQURPHARMA Square Pharmaceuticals৳215.800.5%
+৳975.1m
0.9%PS10.3x
ACMELAB ACME Laboratories৳87.500.8%
+৳148.1m
21.5%PS9.3x
IBNSINA IBN SINA Pharmaceutical Industry৳292.201.3%
+৳115.6m
19.5%PS16.2x
ORIONINFU Orion Infusion৳84.405.0%
+৳81.4m
27.1%PS50.2x
ACTIVEFINE Active Fine Chemicals৳21.100.5%
+৳24.0m
19.9%PS92.3x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News